TearLab announced that it has received Mexican regulatory approval for its osmolarity system, a tool to diagnose and manage patients with dry eye disease. The decision from the Comision Federal para la Proteccion contra Riesgos Sanitarios allows TearLab to begin selling the product in the first half of 2017. The company has signed an exclusive distribution agreement with Cyan Medica, a sales, marketing and distribution organization in the ophthalmic market in Mexico.